Agios Pharmaceuticals Shares Rise on Strong Earnings and Aqvesme Launch
Agios Pharmaceuticals (AGIO) shares surged 11.2% this week following strong first-quarter earnings and the commercial launch of Aqvesme. The company reported $20.7 million in sales for the quarter, up from $8.7 million in the same period in 2025. Key pipeline updates, including tebapivat, are expected in 2026.
Topics: Earnings Report Pharmaceuticals Pipeline Updates Stock Performance